Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer

NCT01724801 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastasis
Non Small Cell Lung Cancer

Interventions

RADIATION: whole brain radiation(WBI)
DRUG: Icotinib

Sponsor

Guangdong Association of Clinical Trials

Collaborators

[object Object]